# data[].attributes.body
A vial of glargine (analogue insulin) costs between $180-$200.

(Brent Lale. (2019). Americans travel to Canada to buy diabetes drugs at one-tenth of the price. Available: https://www.ctvnews.ca/health/americans-travel-to-canada-to-buy-diabetes-drugs-at-one-tenth-of-the-price-1.4488464#:~:text=HEALTH-, Americans%20travel%20to%20Canada%20to%20buy%20diabetes,one%2Dtenth%20. Last accessed: 11/11/2021)

# data[].attributes.body
A vial of glargine (analogue insulin) costs $14

(Brent Lale. (2019). Americans travel to Canada to buy diabetes drugs at one-tenth of the price. Available: https://www.ctvnews.ca/health/americans-travel-to-canada-to-buy-diabetes-drugs-at-one-tenth-of-the-price-1.4488464#:~:text=HEALTH-, Americans%20travel%20to%20Canada%20to%20buy%20diabetes,one%2Dtenth%20. Last accessed: 11/11/2021)

# data[].attributes.location_name
Walmart Supercentre, Dougall Avenue, Windsor, ON, Canada

# data[].attributes.headline
Walmart Supercentre, Dougall Avenue, Windsor, ON, Canada

# data[].attributes.subject
Walmart Supercentre, Dougall Avenue, Windsor, ON, Canada

# data[].attributes.body
Dozens of Americans travelled here in 2019 (and regularly) to buy diabetes drugs for roughly 1/10th of the cost in the US.
One individual paid US$234 in Ontario. The same supply would have cost US$3,060 in the US.
Prices for life-saving diabetes drugs have risen so significantly that 1/4 of Americans with diabetes have to ration their medication.
Another woman's son died aged 26 two years previously when he lost his drug insurance and was forced to ration his insulin. They hadn't known it was legal to purchase insulin in Canada and bring it back to the US.

(Brent Lale. (2019). Americans travel to Canada to buy diabetes drugs at one-tenth of the price. Available: https://www.ctvnews.ca/health/americans-travel-to-canada-to-buy-diabetes-drugs-at-one-tenth-of-the-price-1.4488464#:~:text=HEALTH-, Americans%20travel%20to%20Canada%20to%20buy%20diabetes,one%2Dtenth%20. Last accessed: 11/11/2021)

# data[].attributes.body
Children with Type 1 diabetes living in rural areas have a life expectancy of just 7 months without access to insulin injections. Equivalent to that of a British child in the pre-insulin 100 years ago.

(Emely Recinos. (2021). Accessing Insulin. Available: https://www.borgenmagazine.com/accessing-insulin/. Last accessed: 11/11/2021)

# data[].attributes.body
The amount of insulin needed for a month would cost a worker "the equivalent of 5.5 days of pay per month," which amounts to 20% of their earnings.

(Emely Recinos. (2021). Accessing Insulin. Available: https://www.borgenmagazine.com/accessing-insulin/. Last accessed: 11/11/2021)

# data[].attributes.headline
By 2030, developing countries will account for 78% of all diabetes cases in the world.

# data[].attributes.subject
By 2030, developing countries will account for 78% of all diabetes cases in the world.

# data[].attributes.headline
In 2016, diabetes accounted for around 1.6 million annual global deaths.

# data[].attributes.subject
In 2016, diabetes accounted for around 1.6 million annual global deaths.

# data[].attributes.body
It is estimated that 400,000 Syrians are currently dependent on Insulin to survive.

(Khan, Y., et al. (2019). The Management of diabetes in conflict settings: Focus on the Syrian crisis. Diabetes Spectrum.)

# data[].attributes.body
In 2017, 705,700 cases of adult diabetes where reported.

(Khan, Y., et al. (2019). The Management of diabetes in conflict settings: Focus on the Syrian crisis. Diabetes Spectrum.)

# data[].attributes.attachment_caption
Beran, D., Lazo-Porras, M., Mba, C. M., & Mbanya, J. C. (2021). A global perspective on the issue of access to insulin. Diabetologia. https://doi.org/10.1007/s0

# data[].attributes.attachment_caption
Beran, D., Lazo-Porras, M., Mba, C. M., & Mbanya, J. C. (2021). A global perspective on the issue of access to insulin. Diabetologia. https://doi.org/10.1007/s0

# data[].attributes.attachment_caption
Beran, D., Lazo-Porras, M., Mba, C. M., & Mbanya, J. C. (2021). A global perspective on the issue of access to insulin. Diabetologia. https://doi.org/10.1007/s0

# data[].attributes.attachment_caption
Beran, D., Lazo-Porras, M., Mba, C. M., & Mbanya, J. C. (2021). A global perspective on the issue of access to insulin. Diabetologia. https://doi.org/10.1007/s0

# data[].attributes.attachment_caption
Beran, D., Lazo-Porras, M., Mba, C. M., & Mbanya, J. C. (2021). A global perspective on the issue of access to insulin. Diabetologia. https://doi.org/10.1007/s0

# data[].attributes.headline
A study (2019) of 13 LMICs found mean availability of insulin was 55-80% in facilities that should have had 100% availability on the day of study.

# data[].attributes.subject
A study (2019) of 13 LMICs found mean availability of insulin was 55-80% in facilities that should have had 100% availability on the day of study.

# data[].attributes.location_name
World Health Organization, Avenue Appia, Geneva, Switzerland

# data[].attributes.attachment_caption
Beran, D., Lazo-Porras, M., Mba, C. M., & Mbanya, J. C. (2021). A global perspective on the issue of access to insulin. Diabetologia. https://doi.org/10.1007/s0

# data[].attributes.headline
World Health Organization, Avenue Appia, Geneva, Switzerland

# data[].attributes.subject
World Health Organization, Avenue Appia, Geneva, Switzerland

# data[].attributes.location_name
Sub Saharan Africa Research and Training Center P.L.C(SART Consult), Addis Ababa, Ethiopia

# data[].attributes.body
Only 1 in 7 (type 2 diabetes) people have access to the insulin they need.
(Beran, D., et al. (2021). A global perspective on the issue of access to insulin. Diabetologia.

# data[].attributes.headline
Globally 1 in 2 people (type 2 diabetics) have access to the insulin they need. 

# data[].attributes.subject
Globally 1 in 2 people (type 2 diabetics) have access to the insulin they need. 

# data[].attributes.headline
Eli Lilly, Novo Nordisk and Sanofi have a 96% share of the insulin marked by volume and hold 99% of the market by value!

# data[].attributes.subject
Eli Lilly, Novo Nordisk and Sanofi have a 96% share of the insulin marked by volume and hold 99% of the market by value!

# data[].attributes.location_name
Boston University Photonics Building (PHO), College of Engineering, St Mary's St, Boston, MA, USA

# data[].attributes.headline
Boston University Photonics Building (PHO), College of Engineering, St Mary's St, Boston, MA, USA

# data[].attributes.subject
Boston University Photonics Building (PHO), College of Engineering, St Mary's St, Boston, MA, USA

# data[].attributes.location_name
University of Alberta, Edmonton, AB, Canada

# data[].attributes.headline
University of Alberta, Edmonton, AB, Canada

# data[].attributes.subject
University of Alberta, Edmonton, AB, Canada

# data[].attributes.location_name
Indiana University School of Medicine, West 10th Street, Indianapolis, IN, USA

# data[].attributes.headline
Indiana University School of Medicine, West 10th Street, Indianapolis, IN, USA

# data[].attributes.subject
Indiana University School of Medicine, West 10th Street, Indianapolis, IN, USA

# data[].attributes.location_name
The Johns Hopkins University School of Medicine, North Broadway, Baltimore, MD, USA

# data[].attributes.headline
The Johns Hopkins University School of Medicine, North Broadway, Baltimore, MD, USA

# data[].attributes.subject
The Johns Hopkins University School of Medicine, North Broadway, Baltimore, MD, USA

# data[].attributes.location_name
University of Cambridge, Trinity Ln, Cambridge, UK

# data[].attributes.headline
University of Cambridge, Trinity Ln, Cambridge, UK

# data[].attributes.subject
University of Cambridge, Trinity Ln, Cambridge, UK